Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by RetailRubeon Mar 05, 2015 3:38pm
368 Views
Post# 23494892

Next Big Events (Inflection Points for a Higher Stock Price)

Next Big Events (Inflection Points for a Higher Stock Price)TST will be attending the biotech conference in Paris a few days from now.  It's on Monday March 9th per the TST homepage.  After they presented in San Francisco in January, the stock moved up from 21 cents to over 30 cents.

It seems to take 4-5 days for institutional volume to kick in after an investor conference, based on our experience with the San Francisco event.  I recall a porfolio manager in a news article saying their team met every Monday morning with the CEO in an "investment committee review" to pitch their best ideas.  Then they were given the go-ahead to start buying, but not too fast or they would tip their hand that they were interested.  Therefore, if I'm correct, we should start to see buying pressure from Anonymous starting on Monday March 16, based on what is said in Paris.

It was nice to get one of the analyst reports mentioned at the AGM.  How long before the second one gets released?  It occurred to me that analysts might not want to be first to publish.  If they drag their heels, then they can see what the other guy had for a target price.  They might not want to appear too much higher, to avoid risking their credibility.

Finally, it occurred to me that the analyst report's  $1.25/share 12 month target price might have started with a share price and "back-solved" to a revenue forecast.  This is to avoid showing too high a share price.  The penetration ramp-up and maximum market share numbers in the analyst report seem conservative.  But if they needed to keep EPS down ...
<< Previous
Bullboard Posts
Next >>